Proteon Therapeutics Inc (PRTO): Deerfield Management Discloses Post-IPO 6.7% Stake
James E.
Auxilium Pharmaceuticals Inc (AUXL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Andromeda Capital Larry Motola | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Amici Capital Paul Orlin And Alex Porter | 0 | $0 | 0% | |
| 4. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 0 | $0 | 0% | |
| 5. | Tiger Legatus Capital Jesse Ro | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 56,000 | Officer, Director | 56,579 | 2012-12-14 | Filing | |
| $20.10 | 9,700 | Director | 10,000 | 2012-02-28 | Filing | |
| $20.09 | 300 | Director | 300 | 2012-02-28 | Filing | |
| $15.54 | 1,610 | Officer | 26,839 | 2011-11-03 | Filing | |
| $21.98 | 3,911 | Large Shareholder | 149,968 | 2011-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $34.00 | 18,000 | Director | 10,000 | 2014-12-05 | Filing | |
| $34.00 | 7,430 | Director | 10,000 | 2014-12-05 | Filing | |
| $34.00 | 25,000 | Director | 17,430 | 2014-12-05 | Filing | |
| $33.97 | 40,000 | Officer, Director | 217,778 | 2014-12-05 | Filing | |
| $33.85 | 9,689 | Director | 10,361 | 2014-12-05 | Filing |
Institutional Investors' Holdings
News See All
Perrigo Company (PRGO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
In the eyes of many traders, hedge funds are perceived as useless, outdated financial vehicles of a period lost to current times.
Auxilium Pharmaceuticals, Inc. (AUXL): Are Hedge Funds Right About This Stock?
To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times.
Auxilium Pharmaceuticals, Inc. (AUXL): Huge Potential For First Line Therapy For Frozen Shoulder
Xiaflex from Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) is used to treat Dupuytren’s contracture.
This Metric Says You Are Smart to Buy USANA Health Sciences, Inc. (USNA)
USANA Health Sciences, Inc. (NYSE:USNA) was in 14 hedge funds' portfolio at the end of March.
This Metric Says You Are Smart to Sell Nature's Sunshine Prod. (NATR)
To most investors, hedge funds are viewed as underperforming, outdated financial tools of years past.
Identifying the Biggest Gem in Antares Pharma Inc (ATRS)'s Pipeline
Following the publication of my article on the blockbuster potential of Antares Pharma Inc (NASDAQ:ATRS)'s transformational product (Otrexup), I have been inundated with reader requests to conduct a ...
Perrigo Company (PRGO): What's The Smart Money Think?
Perrigo Company (NASDAQ:PRGO) was in 24 hedge funds' portfolio at the end of March. PRGO has seen an increase in hedge fund interest in recent months.
The Third Time Is Not the Charm for Endo Health Solutions Inc (ENDP)
If there were ever any advice I'd wish to impart to the management at Endo Health Solutions Inc (NASDAQ:ENDP)'s subsidiary Endo Pharmaceuticals, it would be that sometimes it's better to walk away than...
Tesoro Corporation (TSO), Krispy Kreme Doughtnuts (KKD), Medidata Solutions Inc (MDSO) - Sell in May, But Don't Go Away
The most recent high for the S&P qualified the market under a 'sell' criteria for my Investing Strategy.
Billionaire Hedge Funds
